By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

Newborn Declared Dead, Then Found Alive: Inquiry Ordered at Rawalpindi Hospital

Last updated: January 4, 2026 10:22 pm
Irma Khan
Share
SHARE

RAWALPINDI: A deeply troubling incident has emerged from Holy Family Hospital, Rawalpindi, where a two-day-old newborn was mistakenly declared dead and issued a death certificate—only to later be found alive and rushed onto life support. The incident has triggered an official inquiry and renewed concerns over medical protocols in public hospitals.

According to hospital sources, the newborn—born to a woman identified as Rubina—was in critical condition shortly after birth. In what officials have described as a premature and erroneous assessment, attending doctors declared the infant deceased and issued a formal death certificate, stating that the body had been handed over to the family.

Signs of life discovered after certificate issued

Shortly after the documentation was completed, hospital staff noticed faint signs of life in the newborn. The infant was immediately transferred to a ventilator in the neonatal care unit, where medical teams are currently providing intensive treatment.

The death certificate reportedly carries the stamp and signature of Dr. Tayyaba Sadaf, prompting administrative scrutiny into the circumstances surrounding the declaration.

Hospital administration orders formal inquiry

Following the incident, Medical Superintendent Dr. Akhtar Mahmood Malik constituted an inquiry committee to investigate the lapse. The committee is being led by Dr. Hina Sattar, Head of the Pediatrics Department at Holy Family Hospital.

Dr. Malik stated that strict disciplinary action would be taken against those found responsible once the inquiry is completed. He emphasized that the incident would be examined in detail to determine whether established medical and verification protocols were followed before issuing the death certificate.

Rare medical condition cited

Hospital officials explained that the newborn was suffering from Lazarus syndrome, a rare medical phenomenon in which breathing and vital signs become extremely faint, sometimes leading to a false assumption of death if not carefully monitored.

Medical experts caution that such cases underscore the importance of multi-step verification, prolonged observation, and senior consultation—particularly in neonatal and critical care settings.

Broader concerns over patient safety

The incident has sparked serious questions about patient safety, medical oversight, and accountability in public sector hospitals. Healthcare professionals and patient rights advocates have called for stricter checks, enhanced training, and clear protocols to prevent similar occurrences in the future.

As the inquiry proceeds, the case stands as a sobering reminder of the life-and-death consequences of procedural lapses in healthcare systems already under strain.

Share This Article
Email Copy Link Print
Previous Article UHS Launches First Psychiatry Discipline-Specific Faculty Council
Next Article Morning Foods That May Support Weight Loss
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
International Labour Day: Workers face rising costs and stalled protections
pakistan
May 1, 2026
Alden Ehrenreich on the unspoken frustration of acting alongside A-listers
Entertainment
May 1, 2026
Govt hikes petrol price by Rs6, diesel by Rs19
Govt hikes petrol price by Rs6, diesel by Rs19
Breaking
May 1, 2026
Goods transporters raise fares by 5%, demand abolition of traffic fines
Goods transporters raise fares by 5%, demand abolition of traffic fines
Business & Commerce Headline
May 1, 2026
Forest Service Research Labs Are Closing
Forest Service Research Labs Are Closing
Climate and Weather Headline
May 1, 2026
Alarming Increase in the Spread of Hepatitis C in Pakistan
Health
May 1, 2026

You Might Also Like

Health

Bones Bonded Instantly with New Glue Innovation

By
Irma Khan
Health

Malaria Cases in Sindh Surge Past 192,000 as Infections Continue to Rise

By
Irma Khan
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

Serious Irregularities Halt Recruitment Process at Jinnah Institute of Cardiology

By
Neha Ashraf
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?